Company Update (NYSE:ACT): Actavis to Present at Morgan Stanley Global Healthcare Conference 2014

[PR Newswire] – DUBLIN, Aug. 26, 2014 /PRNewswire/ — Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, today announced that Brenton Saunders, CEO and President of Actavis, will provide an overview . . . → Read More: Company Update (NYSE:ACT): Actavis to Present at Morgan Stanley Global Healthcare Conference 2014 Similar Articles: Market Update (NYSE:ACT): Actavis Confirms Generic Neupro® Patent Challenge Company Update (NYSE:ACT): Actavis Announces Positive Topline Results From The Phase III Program Of Ceftazidime-Avibactam In Patients With Complicated Intra-Abdominal Infections(cIAI) Company Update – Visa Inc. (NYSE:V) – The Bank of Moscow, S7 Airlines and the Visa global payment system present a co-branded card